|

CD19 Universal CAR-T cells Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
  • The Children's Hospital of Zhejiang University School of Medicine1

Indications

  • Systemic Lupus Erythematosus2
  • Lupus2

Other2 trials

A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
Phase 1/2
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.